Thomas Kofoed is the CEO and co-founder of Alphalyse, a pioneering contract research organization specializing in LC-MS-based protein analysis for the biopharmaceutical industry.

Thomas’s expertise spans regulatory strategy, GMP-compliant host cell protein analysis, and the development of orthogonal methods to support or replace ELISA-based assays.

Since its founding in 2002, Alphalyse has supported over 2,200 clients worldwide, helping biopharmaceutical companies meet regulatory requirements, optimize purification processes, and accelerate product development timelines.